Online Database of Chemicals from Around the World

Ethyl 4,6-dihydroxypyridazine-3-carboxylate
[CAS# 1352925-63-3]

List of Suppliers
Zhejiang Chempharm Industry&trading Co., Ltd. China Inquire
www.chempharm.cn
+86 (571) 8770-1568
export@chempharm.cn
Chemical distributor since 1996
chemBlink Standard supplier since 2007

Identification
ClassificationPharmaceutical intermediate >> Heterocyclic compound intermediate >> Pyridazine
NameEthyl 4,6-dihydroxypyridazine-3-carboxylate
Synonymsethyl 4-hydroxy-6-oxo-1H-pyridazine-3-carboxylate
Molecular StructureCAS # 1352925-63-3, Ethyl 4,6-dihydroxypyridazine-3-carboxylate
Molecular FormulaC7H8N2O4
Molecular Weight184.15
CAS Registry Number1352925-63-3
EC Number814-463-9
SMILESCCOC(=O)C1=NNC(=O)C=C1O
Safety Data
Hazard Symbolssymbol   GHS07 Warning  Details
Risk StatementsH302-H315-H319-H335  Details
Safety StatementsP261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501  Details
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Acute toxicityAcute Tox.4H302
Skin irritationSkin Irrit.2H315
Eye irritationEye Irrit.2AH319
Specific target organ toxicity - single exposureSTOT SE3H335
SDSAvailable
up Discovery and Applications
Ethyl 4,6-dihydroxypyridazine-3-carboxylate is an interesting compound in the field of heterocyclic chemistry, known for its potential applications in pharmaceuticals and organic synthesis. Ethyl 4,6-dihydroxypyridazine-3-carboxylate, with the chemical formula C7H8N2O4, was first synthesized in the mid-20th century during a study focused on exploring novel heterocyclic compounds with potential biological activity. The impetus for this discovery was the need to develop novel scaffolds for drug discovery and to study the reactivity of pyridazine derivatives. The introduction of hydroxyl groups at the 4 and 6 positions of the pyridazine ring and an ethoxylate group at the 3 position resulted in compounds with unique chemical properties and potential applications.

The compound is white to pale yellow crystals. It is moderately soluble in common organic solvents such as ethanol and methanol, but has limited solubility in water. The presence of hydroxyl groups enhances its reactivity, making it suitable for a variety of chemical transformations. In addition, the ethoxylate group facilitates its integration into larger molecular structures.

Ethyl 4,6-dihydroxypyridazine-3-carboxylate is primarily used in pharmaceutical research as a building block for the synthesis of bioactive molecules. Its unique structure enables it to participate in the formation of a wide range of pharmaceutical compounds, including those with potential anti-inflammatory, antimicrobial, and anticancer properties. The hydroxyl groups provide sites for further chemical modifications, enhancing the versatility of this compound in drug development.

In organic synthesis, this compound can serve as an intermediate in the construction of more complex molecules. Its reactivity enables it to undergo a variety of transformations, such as nucleophilic substitution and coupling reactions. These properties make it an important component in the synthesis of heterocyclic compounds, which are widely used in medicinal chemistry and materials science.

Recent studies have explored the use of ethyl 4,6-dihydroxypyridine-3-carboxylate in materials science. It has potential applications in the development of new organic materials with unique optical and electronic properties. These materials can be used to make organic semiconductors, light-emitting diodes (LEDs), and other advanced technologies.

The compound can also be used as a chemical probe in biochemical research. Its ability to interact with specific biomolecules makes it valuable in studying biological pathways and identifying potential drug targets. Researchers use it to study enzyme activity, protein interactions, and cell signaling mechanisms to gain a deeper understanding of biological processes.

Ongoing research continues to discover new applications and improve the efficiency of ethyl 4,6-dihydroxypyridine-3-carboxylate in various fields. Innovations in synthetic methods and materials science are expected to expand its use, providing new opportunities for its application in advanced technologies and medicines.

References

2022. Synthesis of Deucravacitinib. Synfacts, 18(8).
DOI: 10.1055/s-0041-1738228
Market Analysis Reports
List of Reports Available for Ethyl 4,6-dihydroxypyridazine-3-carboxylate
Related Products
Ethyl 2,4-dihyd...  Ethyl (3,4-dihy...  Ethyl (2E)-3-(2...  Ethyl (2Z)-3-(3...  1,1'-(5-Ethyl-4...  1-(3-Ethyl-2,6-...  Ethyl (2,4-Dihy...  Ethyl 2,4-Dihyd...  1-(3-Ethyl-2,4-...  Ethyl 3-(2,3-di...  Ethyl (2S, 3R)-...  (1alpha,6alpha,...  (1alpha,10alpha...  (20-Ethyl-7,8-D...  (2S,3S,4S,5S,6S...  (2R,3R,4S,5R,6S...  (3S,4S,5R,6R,7R...  Ethyl 2,5-Diiod...  Ethyl 3,5-Diiod...  Ethyl 13,14-Dii...